ArticleJournal of robotic surgery2026
Bridging the innovation-evidence chasm: a critical appraisal and roadmap for robotic pancreatic cancer surgery.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer remains one of the most lethal malignancies globally, with its surgical management undergoing profound transformation driven by minimally invasive approaches, particularly robot-assisted systems. This study employs bibliometric analysis combined with thematic synthesis to delineate the research evolution, knowledge structure, and emerging trends in robot-assisted pancreatic surgery from 1999 to 2025. Using CiteSpace software, we analyzed 202 publications from the Web of Science database. Our analysis revealed a distinct three-phase evolutionary trajectory: an emergence phase (1999–2010) focused on technical feasibility, a rapid development phase (2011–2021) emphasizing procedural standardization, and a recent maturation phase (2022–2025) shifting toward outcome evaluation and collaborative research. The knowledge structure has evolved from a singular surgical focus to a multidimensional network encompassing tumor biology, precision imaging, and patient-centered outcomes. “Robotic surgery” serves as a key bridging node connecting these domains. Burst keyword analysis highlights the recent emergence of “international study group,” “cohort studies,” and “surgical outcomes” as predominant research fronts. Collaborative network analysis reveals the United States as the leading contributor, while Italy and Germany serve as crucial international hubs. China demonstrates substantial research output but limited integration into global collaborative networks. While bibliometric trends reflect significant research momentum and technological convergence, this analysis underscores the persistent gap between technical innovation and robust clinical evidence. Future advancement requires prioritized investment in international multicenter trials, standardized training protocols, and deeper integration of artificial intelligence and molecular navigation technologies to substantiate clinical value and improve patient outcomes in this challenging surgical domain.
Indexed as
Identifiers
41793556What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.